Postoperative continuous positive airway pressure to prevent pneumonia, re-intubation, and death after major abdominal surgery (PRISM): a multicentre, open-label, randomised, phase 3 trial:

PRISM trial group

18 June, 2021

NZ Respiratory Research Review Issue 197

Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover Trials:

Luke S. G. E. Howard, Jianguo He, Geoffrey M. J. Watson, Li Huang, John Wharton, Qin Luo, David G. Kiely, Robin Condliffe, Joanna Pepke-Zaba, Nicholas W. Morrell, Karen K. Sheares, Anna Ulrich, Ruilin Quan, Zhihui Zhao, Xiaoli Jing, Chenhong An, Zhihong Liu, Changming Xiong, Peter A. Robbins, Timothy Dawes, Antonio de Marvao, Christopher J. Rhodes, Manuel J. Richter, Henning Gall, Hossein A. Ghofrani, Lan Zhao, Les Huson, and Martin R. Wilkins

1 June, 2021

NZ Respiratory Research Review Issue 190

Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial:

Tom J C Ruffles, MD Vikas Goyal, PhD Julie M Marchant, PhD I Brent Masters, PhD Stephanie Yerkovich, PhD Helen Buntain, PhD Anne Cook Andre Schultz, PhD Prof John W Upham, PhD Anita Champion, BPharm Lesley Versteegh Prof Anne B Chang, PhD

25 May, 2021

NZ Respiratory Research Review Issue 191

Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial:

om J C Ruffles, MD Vikas Goyal, PhD Julie M Marchant, PhD I Brent Masters, PhD Stephanie Yerkovich, PhD Helen Buntain, PhD et al

25 May, 2021

NZ Respiratory Research Review Issue 203

Prevalence and burden of breathlessness in Australian adults: The National Breathlessness Survey—a cross-sectional web-based population survey:

Leanne M. Poulos,Rosario D. Ampon,David C. Currow,Guy B. Marks,Brett G. Toelle,Helen K. Reddel

10 May, 2021

NZ Respiratory Research Review Issue 192

Effectiveness and outcomes of air travel-related TB incident follow-up: a systematic review:

Laura Maynard-Smith, Colin Stewart Brown, Ross Jeremy Harris, Peter Hodkinson, Surinder Tamne, Sarah Ruth Anderson, Dominik Zenner

6 May, 2021

NZ Respiratory Research Review Issue 187

Long-term safety of lumacaftor–ivacaftor in children aged 2–5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, extension study:

Jordana E Hoppe, MD Mark Chilvers, MD Prof Felix Ratjen, MD John J McNamara, MD Caroline A Owen, MD Simon Tian, MD et al.

6 May, 2021

NZ Respiratory Research Review Issue 191

Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial:

Gunn Marit Traaen, Lars Aakerøy, Tove-Elizabeth Hunt, Britt Øverland, Christina Bendz, Lars Øivind Sande, Svend Aakhus, Morten Wang Fagerland, Sigurd Steinshamn, Ole-Gunnar Anfinsen, Richard John Massey, Kaspar Broch, Thor Ueland, Harriet Akre, Jan Pål Loennechen and Lars Gullestad

5 May, 2021

NZ Respiratory Research Review Issue 197

Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication:

Jordan K. Schaefer, MD; Josh Errickson, PhD; Yun Li, PhD; Xiaowen Kong, MA; Tina Alexandris-Souphis, RN; Mona A. Ali, PharmD; Deborah Decamillo, RN, BSN; Brian Haymart, RN, MS; Scott Kaatz, DO, MSc; Eva Kline-Rogers, RN, MS; Jay H. Kozlowski, MD; Gregory D. Krol, MD; Sahana R. Shankar; Suman L. Sood, MD, MSCE; James B. Froehlich, MD, MPH; Geoffrey D. Barnes, MD, MSc

19 April, 2021

NZ Respiratory Research Review Issue 190

Prevalence and prognostic impact of physical frailty in interstitial lung disease: A prospective cohort study:

Mohammed A. Malik Farooqi, Sachi O'Hoski, Sarah Goodwin, Nima Makhdami, Afia Aziz, Gerard Cox, Joshua Wald, Christopher J. Ryerson, Marla K. Beauchamp, Nathan Hambly, Martin Kolb

19 April, 2021

NZ Respiratory Research Review Issue 201